Search Tag: Cancer imaging

Deep Learning Reduces Need for Gadolinium Contrast

2021 26 Oct

Gadolinium-based contrast agents (GBCAs), used during MRI scans, enhance brain tissue contrast. GBCAs are crucial for brain tumour care because they highlight areas with abnormal blood-brain barrier permeability that tumours cause.  This permits monitoring of treatment response and also guide surgical tumour removal.  Disadvantages to using GBCAs include... Read more

Biparametric MRI: A New Standard for Prostate Cancer Imaging?

2021 12 Jul

A lone and discordant voice supported by few at first, biparametric prostate magnetic resonance imaging has been gradually gaining attention and visibility as a reliable, faster, and cheaper alternative to conventional multiparametric magnetic resonance imaging and could become a new standard of care in the near future. Key Points The role... Read more

International Cancer Imaging Society - ICIS 2019

2019 07 Oct

Find ICIS on Social Media   Read more

Location influences imaging follow-up

2019 23 Jan

One of the major problems which is commonly attributed to affect patient outcomes is the failure to follow-up diagnostic imaging in time. It is critical to follow-up diagnostic imaging findings in order to have access to and receive high quality and vital care. Patient location at the time of undergoing imaging is directly related with how likely a... Read more

International Cancer Imaging Society - ICIS 2018

2018 07 Oct

International Cancer Imaging Society Meeting and 18th Annual Teaching Course Read more

Novel Chemical "Dye" Improves Liver Cancer Imaging

2017 06 May

A novel nondiamond-based contrast agent has been developed by a team of scientists from the National University of Singapore. The chemical "dye" can be used to enhance the visibility of internal body structures in MRI and can improve the visualisation of liver cancer tumours. This in turn can facilitate earlier detection and improved treatment strategies.... Read more

Cancer Imaging: The Need to Improve Utilisation Management

2017 10 Jan

Variation in provider ordering preferences and lapses in care coordination are key factors affecting high-cost cancer imaging utilisation, according to a study published in Journal of Cancer Policy. In particular, high-ordering oncologists were found to be substantial drivers of imaging utilisation, with 58 percent more per patient imaging than their... Read more

Need for Radiologists to Solidify Position in Cancer Teams

2016 01 Aug

A new article titled "A New Look at Toxicity in the Era of Precision Oncology: Imaging Findings, Their Relationship With Tumor Response, and Effect on Metastasectomy" states that the increasing use of cancer imaging will require radiologists to solidify their position as central members of the cancer team. The article is published in the American Journal... Read more

New Imaging Model Helps Arrest Pancreatic Cancer Growth

2016 07 Jun

A new non-invasive, image-based tracking of stem cell signals in living animals could provide a strategy to arrest pancreatic cancer growth, especially the most common pancreatic ductal adenocarcinoma, which is extraordinarily lethal, with a 5-year survival rate of just 6 percent. Chemotherapy treatments are poorly effective, in part due to a high... Read more